Skip to main content
OpenTrials

Clinical trial condition

Motor Neuron Disease

Explore clinical trials studying Motor Neuron Disease. Study availability and eligibility vary by location and protocol.

839 public trials 197 recruiting studies
Refine in advanced search Browse all conditions

Motor Neuron Disease trial results

Completed

A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy (SMA)

NCT02628743

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
Locations
  • UZ Gent Ghent, Belgium
  • UZ Leuven Gasthuisberg Leuven, Belgium
  • Hopital Femme Mere Enfant; Medecine Physique et Readaptation Pediatrique - L'ESCALE Bron, France
  • Hôpital Raymond Poincare; Serv. Neurologie et Réanimation pédiatriques - Centre réf. neuromusculaire Garches, France
View all 24 locations
View Trial Details
Completed

Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation

NCT00116558

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Colorado Denver, Colorado, United States
  • University of Miami Miami, Florida, United States
  • University of Kentucky Lexington, Kentucky, United States
  • Henry Ford Hospital Detroit, Michigan, United States
View Trial Details
Completed

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01089010

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States
  • University Neurology Associates Fresno, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Completed

A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01378676

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Florida Jacksonville, Florida, United States
  • University of Kansas Kansas City, Kansas, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01486849

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of California at San Francisco, Fresno Campus, Central California Neurological Institute Fresno, California, United States
  • Coordinated Clinical Research La Jolla, California, United States
  • University of California at Irvine, ALS and Neuromuscular Center Orange, California, United States
  • Hospital for Special Care New Britain, Connecticut, United States
View Trial Details

Related conditions